CDK2 and breast cancer: Besides, we reveal that deletion of RHBDD1 protects breast cancer cells from tumor progression by promoting anti-tumoral properties such as apoptosis, and inhibiting pro-tumoral properties such as proliferation, migration and invasion, as well as cell cycle progression via regulating p-Akt/CDK2 signaling pathway.